These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24962607)

  • 1. A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.
    Cacciotti-Saija C; Langdon R; Ward PB; Hickie IB; Scott EM; Naismith SL; Moore L; Alvares GA; Redoblado Hodge MA; Guastella AJ
    Schizophr Bull; 2015 Mar; 41(2):483-93. PubMed ID: 24962607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia.
    Strauss GP; Granholm E; Holden JL; Ruiz I; Gold JM; Kelly DL; Buchanan RW
    Psychol Med; 2019 Jul; 49(10):1731-1739. PubMed ID: 30180918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
    Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
    Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia.
    Buchanan RW; Kelly DL; Strauss GP; Gold JM; Weiner E; Zaranski J; Chen S; Blatt F; Holden J; Granholm E
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):236-243. PubMed ID: 33783399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
    Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
    J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Interactive Social Cognition Training in Virtual Reality (DiSCoVR) for social cognition and social functioning in people with a psychotic disorder: study protocol for a multicenter randomized controlled trial.
    Nijman SA; Veling W; Greaves-Lord K; Vermeer RR; Vos M; Zandee CER; Zandstra DC; Geraets CNW; Pijnenborg GHM
    BMC Psychiatry; 2019 Sep; 19(1):272. PubMed ID: 31488103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin-augmented social cognitive skills training in schizophrenia.
    Davis MC; Green MF; Lee J; Horan WP; Senturk D; Clarke AD; Marder SR
    Neuropsychopharmacology; 2014 Aug; 39(9):2070-7. PubMed ID: 24637803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
    Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mindfulness-based social cognition training (SocialMIND) versus psychoeducational multicomponent intervention for people with a first episode of psychosis: a study protocol for a randomised controlled trial.
    Mediavilla R; Muñoz-Sanjose A; Rodriguez-Vega B; Bayon C; Palao A; Lahera G; Sanchez-Castro P; Roman E; Cebolla S; de Diego A; Pastor JM; Bravo-Ortiz MF
    BMC Psychiatry; 2019 Jul; 19(1):233. PubMed ID: 31357965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
    Guastella AJ; Einfeld SL; Gray KM; Rinehart NJ; Tonge BJ; Lambert TJ; Hickie IB
    Biol Psychiatry; 2010 Apr; 67(7):692-4. PubMed ID: 19897177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Halverson T; Jarskog LF; Pedersen C; Penn D
    Schizophr Res; 2019 Feb; 204():178-182. PubMed ID: 30243853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
    Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
    Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Cognitive-Behavioral Social Skills Training and Compensatory Cognitive Training for Negative Symptoms of Psychosis: Effects in a Pilot Randomized Controlled Trial.
    Granholm E; Twamley EW; Mahmood Z; Keller AV; Lykins HC; Parrish EM; Thomas ML; Perivoliotis D; Holden JL
    Schizophr Bull; 2022 Mar; 48(2):359-370. PubMed ID: 34665853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial.
    De Coster L; Lin L; Mathalon DH; Woolley JD
    Neuropsychopharmacology; 2019 Oct; 44(11):1925-1931. PubMed ID: 31103018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
    Bechdolf A; Müller H; Stützer H; Wagner M; Maier W; Lautenschlager M; Heinz A; de Millas W; Janssen B; Gaebel W; Michel TM; Schneider F; Lambert M; Naber D; Brüne M; Krüger-Özgürdal S; Wobrock T; Riedel M; Klosterkötter J;
    Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S111-21. PubMed ID: 21860040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
    Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
    Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
    Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
    Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial.
    Brambilla M; Cotelli M; Manenti R; Dagani J; Sisti D; Rocchi M; Balestrieri M; Pini S; Raimondi S; Saviotti FM; Scocco P; de Girolamo G
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1619-28. PubMed ID: 27527256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial.
    Guastella AJ; Boulton KA; Whitehouse AJO; Song YJ; Thapa R; Gregory SG; Pokorski I; Granich J; DeMayo MM; Ambarchi Z; Wray J; Thomas EE; Hickie IB
    Mol Psychiatry; 2023 Feb; 28(2):834-842. PubMed ID: 36302965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.